Alan L. Crane, Director at MOMENTA PHARMACEUTICALS INC (MNTA), sold 62,500 shares at $16.58 ($1.0M) on 2006-12-18, disclosed to the SEC on 2006-12-20.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 1,200 | $19K | 1.9% |
| 2 | $16.01 | 400 | $6K | 0.6% |
| 3 | $16.02 | 1,200 | $19K | 1.9% |
| 4 | $16.03 | 1,360 | $22K | 2.1% |
| 5 | $16.04 | 200 | $3K | 0.3% |
| 6 | $16.05 | 4,593 |
| $74K |
| 7.2% |
| 7 | $16.06 | 300 | $5K | 0.5% |
| 8 | $16.07 | 132 | $2K | 0.2% |
| 9 | $16.08 | 4,764 | $77K | 7.4% |
| 10 | $16.12 | 304 | $5K | 0.5% |
| 11 | $16.15 | 5,275 | $85K | 8.3% |
| 12 | $16.16 | 272 | $4K | 0.4% |
| 13 | $16.30 | 4,500 | $73K | 7.1% |
| 14 | $16.40 | 500 | $8K | 0.8% |
| 15 | $16.42 | 10,404 | $171K | 16.6% |
| 16 | $16.45 | 1,296 | $21K | 2.1% |
| 17 | $16.50 | 2,000 | $33K | 3.2% |
| 18 | $16.51 | 500 | $8K | 0.8% |
| 19 | $16.56 | 200 | $3K | 0.3% |
| 20 | $16.57 | 3,222 | $53K | 5.2% |
| 21 | $16.58 | 600 | $10K | 1.0% |
| 22 | $16.74 | 1,000 | $17K | 1.6% |
| 23 | $16.75 | 600 | $10K | 1.0% |
| 24 | $16.76 | 100 | $2K | 0.2% |
| 25 | $16.80 | 100 | $2K | 0.2% |
| 26 | $16.85 | 6,522 | $110K | 10.7% |
| 27 | $16.90 | 1,900 | $32K | 3.1% |
| 28 | $16.91 | 200 | $3K | 0.3% |
| 29 | $16.95 | 5,000 | $85K | 8.2% |
| 30 | $17.00 | 3,856 | $66K | 6.4% |
| Total | $16.46 avg | 62,500 | $1.0M | 100% |
| Filing → |
| CERU | BUY | 2014-04-15 | $10.3M | — | Filing → |
| MNTA | SELL | 2007-01-12 | $873K | — | Filing → |
| MNTA | SELL | 2006-12-12 | $880K | — | Filing → |